Humanio

Indications For The Immune-Regulative Molecular Therapy

immune regulative molecular therapy

“Similia similibus curator” – “Similar heals Similar”

The success of any cell therapy is primarily connected to the right specification of indications, for which it may be used. The indication groups, which have proven successful over the years in the field of cell therapy are:

  1. Sub-functions of glands with inner secretion
  2. Premature aging and loss of vitality
  3. Burnout syndrome
  4. Chronic-degenerative disorders of the supporting- and vesselapparatus
  5. Degenerative cell diseases
  6. Developmental disorders in childhood
  7. Diseases of the brain and the spinal cord
  8. Potency disorders
  9. General immune deficiency and vulnerability to infections

The treatment follows the priciple of Paracelsus: „Similia similibus curantur“, „Similar heals Similar“ with the help of corresponding healthy xenogeneic organ cells. Heart diseases are treated with heart cells, liver disorders are targeted with liver cells – to name just two examples. Yet, singular cells seldom become diseased. Mostly cell systems are affected, thus making it necessary to treat the other co-affected cells with their corresponding xenogeneic cells as well. Put into practice this means that the molecular therapy mostly makes use of individually composed combinations of cell-types as opposed to using just one kind of cell suspension.